YUHYLYX Trademark

Trademark Overview


On Monday, October 7, 2019, a trademark application was filed for YUHYLYX with the United States Patent and Trademark Office. The USPTO has given the YUHYLYX trademark a serial number of 79273535. The federal status of this trademark filing is REGISTERED as of Tuesday, November 10, 2020. This trademark is owned by Yuyu Pharma,Inc.. The YUHYLYX trademark is filed in the Pharmaceutical Products category with the following description:

Androgen preparations; pharmaceutical agents affecting metabolism; pharmaceutical preparations for treatment of erectile dysfunction and benign prostate hyperplasia; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for inducing erections; pharmaceutical preparations for treatment of conditions affecting urogenital organs; pharmaceutical preparations for prevention of sexual dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treatment of benign prostate hyperplasia; drugs for medical purposes, pharmaceutical drugs and medicines for human purposes, namely, pharmaceutical preparations for the treatment and prevention of ophthalmic, dermatological, urological, hematological, bone, skeletal, respiratory, endocrinological, circulatory, gastroenterological, hormonal, diabetic, muscular, rheumatic, immune system, ocular, ps...
yuhylyx

General Information


Serial Number79273535
Word MarkYUHYLYX
Filing DateMonday, October 7, 2019
Status700 - REGISTERED
Status DateTuesday, November 10, 2020
Registration Number6192057
Registration DateTuesday, November 10, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2020

Trademark Statements


Goods and ServicesAndrogen preparations; pharmaceutical agents affecting metabolism; pharmaceutical preparations for treatment of erectile dysfunction and benign prostate hyperplasia; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for inducing erections; pharmaceutical preparations for treatment of conditions affecting urogenital organs; pharmaceutical preparations for prevention of sexual dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treatment of benign prostate hyperplasia; drugs for medical purposes, pharmaceutical drugs and medicines for human purposes, namely, pharmaceutical preparations for the treatment and prevention of ophthalmic, dermatological, urological, hematological, bone, skeletal, respiratory, endocrinological, circulatory, gastroenterological, hormonal, diabetic, muscular, rheumatic, immune system, ocular, psychiatric, cognitive, mood, infectious, oncological, gynecological, sexual, and pediatric disorders; hormones for medical purposes; pharmaceutical drugs in the nature of pharmaceutical preparations used for the treatment of Alopecia, Androgenetic Alopecia, and Alopecia Areata; pharmaceutical preparations for treatment of premature ejaculation; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for treatment of conditions affecting respiratory organs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameYuyu Pharma,Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameYuyu Pharma,Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameYuyu Pharma,Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, December 5, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 14, 2019APPLICATION FILING RECEIPT MAILED
Friday, January 10, 2020ASSIGNED TO EXAMINER
Friday, January 17, 2020NON-FINAL ACTION WRITTEN
Saturday, January 18, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 10, 2020REFUSAL PROCESSED BY MPU
Monday, February 10, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 28, 2020REFUSAL PROCESSED BY IB
Monday, July 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 22, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 22, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, July 22, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 22, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, July 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 25, 2020PUBLISHED FOR OPPOSITION
Tuesday, August 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, February 10, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 23, 2021FINAL DISPOSITION PROCESSED
Wednesday, February 24, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, March 14, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 10, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED